Endotoxin release and endotoxin neutralizing capacity during colonoscopy

被引:18
作者
Bölke, E
Jehle, PM
Storck, M
Nothnagel, B
Stanescu, A
Orth, K
机构
[1] Univ Ulm, Dept Surg, D-89075 Ulm, Germany
[2] Univ Ulm, Dept Internal Med 2, D-89081 Ulm, Germany
关键词
endotoxin; endotoxin neutralizing capacity; colonoscopy;
D O I
10.1016/S0009-8981(00)00373-9
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
In 38 patients who underwent elective colonoscopy, endotoxin and endotoxin neutralizing capacity (ENC) were determined by use of the limulus-amebocyte-lysate test. A control group of 10 patients, prepared for colonoscopy, were sampled in the same manner as the study group prior to endoscopy. Elevated endotoxin plasma levels were only found when comparing the plasma levels before endoscopy with the highest levels available during endoscopy. The timed endotoxin plasma levels did not change significantly by use of the conventional limulus amebocyte test. However, ENC was found to decrease significantly 5 min after the onset of endoscopy. Maximal values were reached at the end of colonoscopy which recovered completely 24 h later. These results, obtained in a population which did not receive any infusions, demonstrate that the half life of endotoxin in the circulation seems to be very short and therefore endotoxin cannot itself be detected. On the other hand, small amounts of endotoxin reaching the blued stream are able to reduce ENC which can be analyzed by a modified limulus-amebocyte-lysate test. With the use of ENC and plasma endotoxin determinations, we are able to show significant; endotoxemia during a minimal invasive procedure such as colonoscopy. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:49 / 53
页数:5
相关论文
共 22 条
[1]  
ANDERSEN LW, 1987, J THORAC CARDIOV SUR, V93, P115
[2]   ACTION OF RECOMBINANT HUMAN INTERLEUKIN-6, INTERLEUKIN-1-BETA AND TUMOR NECROSIS FACTOR-ALPHA ON THE MESSENGER-RNA INDUCTION OF ACUTE-PHASE PROTEINS [J].
ANDUS, T ;
GEIGER, T ;
HIRANO, T ;
KISHIMOTO, T ;
HEINRICH, PC .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (05) :739-746
[3]   INCIDENCE AND PATHOPHYSIOLOGICAL RELEVANCE OF POSTOPERATIVE ENDOTOXEMIA [J].
BERGER, D ;
SCHMIDT, UM ;
OTT, S ;
SEIDELMANN, M ;
MARTIN, R ;
BEGER, HG .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 1995, 11 (04) :285-290
[4]   DEMONSTRATION OF AN INTERACTION BETWEEN TRANSFERRIN AND LIPOPOLYSACCHARIDE - AN INVITRO STUDY [J].
BERGER, D ;
SCHLEICH, S ;
SEIDELMANN, M ;
BEGER, HG .
EUROPEAN SURGICAL RESEARCH, 1991, 23 (5-6) :309-316
[5]  
BERGER D, 1991, POSTGRAD SURG, V3, P174
[6]  
BUELLER HR, 1985, PROG CLIN BIOL RES, V189, P405
[7]  
BUSCH J, 1988, Z RHEUMATOL, V47, P156
[8]   CIRCULATING ENDOTOXIN AND TUMOR-NECROSIS-FACTOR DURING PEDIATRIC CARDIAC-SURGERY [J].
CASEY, WF ;
HAUSER, GJ ;
HANNALLAH, RS ;
MIDGLEY, FM ;
KHAN, WN .
CRITICAL CARE MEDICINE, 1992, 20 (08) :1090-1096
[9]   INTERLEUKIN-6 IS THE MAJOR REGULATOR OF ACUTE PHASE PROTEIN-SYNTHESIS IN ADULT HUMAN HEPATOCYTES [J].
CASTELL, JV ;
GOMEZLECHON, MJ ;
DAVID, M ;
ANDUS, T ;
GEIGER, T ;
TRULLENQUE, R ;
FABRA, R ;
HEINRICH, PC .
FEBS LETTERS, 1989, 242 (02) :237-239
[10]   RESPONSE OF SERUM INTERLEUKIN-6 IN PATIENTS UNDERGOING ELECTIVE SURGERY OF VARYING SEVERITY [J].
CRUICKSHANK, AM ;
FRASER, WD ;
BURNS, HJG ;
VANDAMME, J ;
SHENKIN, A .
CLINICAL SCIENCE, 1990, 79 (02) :161-165